Carregant...
Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy
C3 glomerulopathy (C3G) defines a group of untreatable ultra-rare renal diseases caused by uncontrolled activation of the alternative complement pathway. Nearly half of patients progress to end stage renal failure within 10 years. Cp40, a second-generation compstatin analog in clinical development,...
Guardat en:
| Publicat a: | Immunobiology |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4510458/ https://ncbi.nlm.nih.gov/pubmed/25982307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imbio.2015.04.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|